Increasing tumor size, extrahepatic disease, higher CA 19-9 levels, portal vein thrombus, the presence of satellite lesions, and IDH1, TP53, and NRAS mutations were all significantly associated with an increased likelihood of intrahepatic distant metastasis. Here, TP53 is linked to neoplasm.